Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Works matching AU Pisa, Pavel
Results: 33
1
2
Wireless communication for control of manipulation systems.
- Published in:
- Archives of Control Sciences, 2012, v. 22, n. 1, p. 29, doi. 10.2478/v10170-011-0010-6
- By:
- Publication type:
- Article
3
Induction of antigen-specific CD4.
- Published in:
- European Journal of Immunology, 1990, v. 20, n. 2, p. 369, doi. 10.1002/eji.1830200221
- By:
- Publication type:
- Article
4
Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue.
- Published in:
- APMIS, 2010, v. 118, n. 5, p. 360, doi. 10.1111/j.1600-0463.2010.02604.x
- By:
- Publication type:
- Article
5
Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
- Published in:
- APMIS, 2008, v. 116, n. 6, p. 491, doi. 10.1111/j.1600-0463.2008.01020.x
- By:
- Publication type:
- Article
6
Increase of serum interleukin-2 and regression of myeloma after rhGM-CSF treatment of drug induced bone marrow aplasia.
- Published in:
- Hematological Oncology, 1991, v. 9, n. 3, p. 129, doi. 10.1002/hon.2900090303
- By:
- Publication type:
- Article
7
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 5, p. 653, doi. 10.1007/s00262-008-0587-1
- By:
- Publication type:
- Article
8
Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1451, doi. 10.1007/s00262-008-0482-9
- By:
- Publication type:
- Article
9
Tumor specific phage particles promote tumor regression in a mouse melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 677, doi. 10.1007/s00262-006-0227-6
- By:
- Publication type:
- Article
10
Tumor escape mechanisms in prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 81, doi. 10.1007/s00262-005-0110-x
- By:
- Publication type:
- Article
11
Comparison of PSA-specific CD8<sup>+</sup> CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 12, p. 1085, doi. 10.1007/s00262-004-0559-z
- By:
- Publication type:
- Article
12
Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X<sub>L</sub>.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 3, p. 139, doi. 10.1007/s00262-002-0265-7
- By:
- Publication type:
- Article
13
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
- Published in:
- Oncogene, 2000, v. 19, n. 45, p. 5123, doi. 10.1038/sj.onc.1203890
- By:
- Publication type:
- Article
14
Current perspectives in the treatment of advanced prostate cancer.
- Published in:
- Medical Oncology, 2007, v. 24, n. 3, p. 273, doi. 10.1007/s12032-007-0017-9
- By:
- Publication type:
- Article
15
Serum Tumor Necrosis Factor Levels and Disease Dissemination in Leprosy and Leishmaniasis.
- Published in:
- Journal of Infectious Diseases, 1990, v. 161, n. 5, p. 988
- By:
- Publication type:
- Article
16
Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.
- Published in:
- International Journal of Cancer, 1995, v. 63, n. 3, p. 366, doi. 10.1002/ijc.2910630311
- By:
- Publication type:
- Article
17
The epstein-barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in burkitt lymphoma lines.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 2, p. 240, doi. 10.1002/ijc.2910570218
- By:
- Publication type:
- Article
18
Presence and specificity of tumor associated lymphocytes from ascites fluid in prostate cancer.
- Published in:
- Prostate, 2005, v. 65, n. 1, p. 20, doi. 10.1002/pros.20229
- By:
- Publication type:
- Article
19
Identification of an immunodominant H‐2Db‐restricted CTL epitope of human PSA.
- Published in:
- Prostate, 2005, v. 64, n. 1, p. 50, doi. 10.1002/pros.20221
- By:
- Publication type:
- Article
20
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
- Published in:
- Prostate, 2005, v. 62, n. 3, p. 217, doi. 10.1002/pros.20135
- By:
- Publication type:
- Article
21
Characterization of add(I)(p36) in non-hodgkin lymphomas by fluorescence in situ hybridization.
- Published in:
- Genes, Chromosomes & Cancer, 1995, v. 13, n. 1, p. 34, doi. 10.1002/gcc.2870130106
- By:
- Publication type:
- Article
22
Extramedullary progression of multiple myeloma following GM-CSF treatment - grounds for caution?
- Published in:
- European Journal of Haematology, 1992, v. 49, n. 2, p. 108, doi. 10.1111/j.1600-0609.1992.tb00040.x
- By:
- Publication type:
- Article
23
Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
24
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
- Published in:
- Acta Oncologica, 2006, v. 45, n. 7, p. 870, doi. 10.1080/02841860600954875
- By:
- Publication type:
- Article
25
Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
- Published in:
- 2006
- By:
- Publication type:
- Letter
26
Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007226
- By:
- Publication type:
- Article
27
Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 9, p. 1637, doi. 10.1038/mt.2009.120
- By:
- Publication type:
- Article
28
Enhancement of Cellular Immune Response to a Prostate Cancer DNA Vaccine by Intradermal Electroporation.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 2, p. 320, doi. 10.1016/j.ymthe.2005.08.005
- By:
- Publication type:
- Article
29
Expression of the signal transduction molecule ζ in peripheral and tumour-associated lymphocytes in Hodgkin's disease in relation to the Epstein–Barr virus status of the tumour cells.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 4, p. 765, doi. 10.1046/j.0007-1048.2002.03342.x
- By:
- Publication type:
- Article
30
High levels of lung resistance related protein mRNA in leukaemic cells from patients with acute myelogenous leukaemia are associated with inferior response to chemotherapy and prior treatment with mitoxantrone.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 3, p. 627, doi. 10.1046/j.1365-2141.1999.01611.x
- By:
- Publication type:
- Article
31
Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 2, p. 346, doi. 10.1046/j.1365-2141.1999.01176.x
- By:
- Publication type:
- Article
32
Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 5, p. 1367, doi. 10.1046/j.1365-2141.1998.00969.x
- By:
- Publication type:
- Article
33
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 2, p. 393, doi. 10.1046/j.1365-2141.1996.00358.x
- By:
- Publication type:
- Article